Clinical trial
The Impact of Telemonitoring on Correct Drug Use, Complications and Quality of Life Among Patients With Multiple Myeloma (MM)
NCT05964270 is registered in ClinicalTrials.gov with Isala as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Telemonitoring on Correct Drug Use, Complications and Quality of Life Among Patients With Multiple Myeloma (MM)
- Lead sponsor
- Isala
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 1, 2021
- Completion date
- July 1, 2024
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.